Company
ChinaJiangsu Center for Safety Evaluation of Drugs, Nanjing, China – FDA Inspections
Inspection records and compliance data for Jiangsu Center for Safety Evaluation of Drugs in Nanjing. 1 FDA inspection on record, 1 Form 483, last inspected April 03, 2026.
Company Profile
This profile covers Jiangsu Center for Safety Evaluation of Drugs based in Nanjing, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected April 3, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 3, 2026 | Not classified | Human Drugs | 1313256 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Markwins Cosmetic (ShenZhen) Co., Ltd.
Zhendong Chen
Hangzhou Zhongbo Industrial Co., Ltd.
Chuanben Chen, MD
Tianjin Modern Pharmaceutical Development Institute
Ping Jin, MD, PhD
Nanjing Clinical Tech Laboratories Inc.
Fantastic Bioimaging Co., Ltd.
Caicun Zhou, MD
Shandong Xinbo Pharmaceutical Research Co., Ltd., Shandong Xinbo Center for Drug Safety Evaluation and Research
Company Information
Name
Jiangsu Center for Safety Evaluation of Drugs
FEI Number
3015802796
Address
No. 30 Puzhu South Road, Zhujiangzhen Pukou District, Nanjing, China
Country
China
ID: 2c0483fc-c822-4d4a-83fb-b66b8a2641d5